Enimmune corporation (6564.TWO)
TWD 26.45
(-0.75%)
TWD 26.45
(-0.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 43.49 Million | 188.41 Million | 109.82 Million | 22.87 Million | 1.94 Million |
| Cost of Revenue | 66.86 Million | 167.57 Million | 71.09 Million | 14.65 Million | 1.17 Million |
| Gross Profit | -23.37 Million | 20.84 Million | 38.72 Million | 8.21 Million | 769 Thousand |
| Operating Expenses | 220.1 Million | 302.33 Million | 97.32 Million | 90.94 Million | 58.44 Million |
| Selling, General and Administrative Expenses | 80.83 Million | 54.96 Million | 42.57 Million | 32.08 Million | 22.61 Million |
| Research and Development Expenses | 139.27 Million | 247.37 Million | 54.75 Million | 58.85 Million | 50.02 Million |
| Other Expenses | - | 18.35 Million | 9.25 Million | 6.76 Million | - |
| Cost and Expenses | 286.96 Million | 469.91 Million | 168.42 Million | 105.59 Million | 59.61 Million |
| Operating Income | -243.47 Million | -261.85 Million | -46.95 Million | -74.27 Million | -71.86 Million |
| Interest Expense | 977 Thousand | 315 Thousand | 225 Thousand | 176 Thousand | 7000.00 |
| Income Tax Expense | - | -19.12 Million | - | - | - |
| Earnings before Tax | -237.69 Million | -267.08 Million | -47.24 Million | -74.45 Million | -56.64 Million |
| Net Income | -223.74 Million | -247.96 Million | -47.24 Million | -74.45 Million | -56.64 Million |
| Earnings Per Share Basic | -3.40 | -3.88 | -0.78 | -1.39 | -1.28 |
| Earnings Per Share Diluted | -3.40 | -3.88 | -0.78 | -1.39 | -1.28 |
| Weighted Average Shares Outstanding | 65.86 Million | 63.97 Million | 60.2 Million | 53.6 Million | 44.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.86 Million | 63.97 Million | 60.2 Million | 53.6 Million | 44.14 Million |
| Gross Margin | -0.54 | 0.11 | 0.35 | 0.36 | 0.40 |
| EBIT Margin | -5.26 | -1.35 | -0.35 | -2.94 | -33.94 |
| Profit Margin | -5.14 | -1.32 | -0.43 | -3.25 | -29.14 |
| EBITDA | -228.96 Million | -258.42 Million | -38.39 Million | -67.29 Million | -50.72 Million |
| Earnings Before Tax Margin | -5.60 | -1.39 | -0.43 | -3.25 | -36.97 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.6 Million | 10.16 Million | 15.24 Million | 43.49 Million | 15.24 Million | 6.5 Million |
| Cost of Revenue | 10.15 Million | 6.11 Million | 26.79 Million | 66.86 Million | 26.79 Million | 6.63 Million |
| Gross Profit | 6.44 Million | 4.05 Million | -11.55 Million | -23.37 Million | -11.55 Million | -135 Thousand |
| Operating Expenses | 52.21 Million | 49.23 Million | 64.78 Million | 219.93 Million | 64.78 Million | 42.85 Million |
| Selling, General and Administrative Expenses | 22.34 Million | 19.82 Million | 24.25 Million | - | 24.25 Million | 16.16 Million |
| Research and Development Expenses | 29.87 Million | 21.31 Million | 41.68 Million | - | 41.68 Million | 27.95 Million |
| Other Expenses | - | - | - | 4.82 Million | - | - |
| Cost and Expenses | 62.37 Million | 55.34 Million | 91.57 Million | 286.8 Million | 91.57 Million | 49.49 Million |
| Operating Income | -45.77 Million | -37.08 Million | -77.48 Million | -236.54 Million | -77.48 Million | -44.24 Million |
| Interest Expense | - | - | - | 977 Thousand | - | - |
| Income Tax Expense | -4.78 Million | -2.53 Million | -3.16 Million | -13.94 Million | -3.16 Million | -3.81 Million |
| Earnings before Tax | -44.42 Million | -45.18 Million | -76.17 Million | -237.69 Million | -76.17 Million | -42.66 Million |
| Net Income | -39.64 Million | -42.64 Million | -73.01 Million | -223.74 Million | -73.01 Million | -38.85 Million |
| Earnings Per Share Basic | -0.58 | -0.64 | -1.11 | - | -1.11 | -0.59 |
| Earnings Per Share Diluted | -0.58 | -0.64 | -1.11 | - | -1.11 | -0.59 |
| Weighted Average Shares Outstanding | 68.2 Million | 67.16 Million | 65.78 Million | 65.8 Million | 65.78 Million | 65.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 68.2 Million | 67.16 Million | 65.8 Million | 65.8 Million | 65.8 Million | 65.8 Million |
| Gross Margin | 0.39 | 0.40 | -0.76 | -0.54 | -0.76 | -0.02 |
| EBIT Margin | -2.67 | -3.46 | -4.93 | - | -4.93 | -6.58 |
| Profit Margin | -2.39 | -4.20 | -4.79 | -5.14 | -4.79 | -5.98 |
| EBITDA | -44.37 Million | -35.19 Million | -75.18 Million | - | -75.18 Million | -42.75 Million |
| Earnings Before Tax Margin | -2.76 | -3.65 | -5.08 | -5.44 | -5.08 | -6.81 |
RAJOOENG
CPT
IDEA
ED
LYV
ALCRB